Physician profile
Michelle Warncke
NPI 1497487631
$981.31
in general payments reported to CMS, 2019-2025
12 companies · $21.95 in 2025
The $21.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $189 · 2023: $185 · 2024: $586 · 2025: $21.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $381.85 | 2024 | Rezdiffra |
| Glaxosmithkline, LLC. | $156.20 | 2022-2024 | Shingrix, Bexsero, Pediarix |
| Dexcom, INC. | $81.90 | 2023 | Dexcom G7 Gss (161) |
| Boston Scientific Corporation | $77.07 | 2024 | Watchman Flx |
| Novo Nordisk INC | $56.43 | 2022-2023 | Ozempic |
| E.R. Squibb & Sons, L.L.C. | $52.09 | 2022-2024 | Opdivo |
| Grifols USA, LLC | $40.09 | 2024-2025 | Prolastin-C Liquid |
| Abbvie INC. | $38.32 | 2023-2024 | Vraylar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.63 | 2022-2024 | Lifevest |
| Irhythm Technologies, INC. | $30.88 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $19.00 | 2023 | |
| Bioxcel Therapeutics, INC. | $14.85 | 2023 | Igalmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Warncke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.